Please use this identifier to cite or link to this item:
Title: Synergistic effect of vascular endothelial growth factor and granulocyte colony-stimulating factor double gene therapy in mouse limb ischemia
Authors: Sacramento, Chester Bittencourt
Silva, Flavia Helena da
Nardi, Nance Beyer
Yasumura, Eduardo Gallatti
Costa Baptista-Silva, Jose Carlos [UNIFESP]
Beutel, Abram [UNIFESP]
Campos, Ruy Ribeiro de [UNIFESP]
Moraes, Jane Zveiter de [UNIFESP]
Silva Junior, Hamilton
Samoto, Vivian Yochiko
Borojevic, Radovan
Han, Sang Won [UNIFESP]
Universidade Federal de São Paulo (UNIFESP)
Univ Fed Rio Grande do Sul
Excell Biomed Serv
Universidade Federal do Rio de Janeiro (UFRJ)
DIPRO Inst Nacl Metrol Normalizacao & Controle Qu
Keywords: angiogenesis
limb ischemia
Issue Date: 1-Mar-2010
Publisher: Wiley-Blackwell
Citation: Journal of Gene Medicine. Chichester: John Wiley & Sons Ltd, v. 12, n. 3, p. 310-319, 2010.
Abstract: Background Vascular endothelial growth factor (VEGF) has mostly been tested to treat ischemic diseases, although the outcomes obtained are not satisfactory. Our hypothesis is that the local transient expression of VEGF and stem cell mobilizer granulocyte colony-stimulating factor (G-CSF) genes in ischemic limbs can complement their activities and be more efficient for limb recovery.Methods Limb ischemia was surgically induced in mice and 50 mu g of VEGF and/or G-CSF genes were locally transferred by electroporation. After 3-4 weeks, evidence of necrosis by visual inspection, capillary density, muscle mass, muscle force and hematopoietic cell mobilization were evaluated.Results After 4 weeks, 70% and 90% of the animals of the ischemic group (IG) and VEGF-treated group (VG), respectively, presented limb necrosis, in contrast to only 10% observed in the group of mice treated with both VEGF and G-CSF genes (VGG). Recovery of muscle mass and muscle force was higher than 60% in the VGG compared to the non-ischemic group. the mobilization of Sca1+ cells and neutrophils was also higher in the VGG, which may explain the lower level of necrosis observed in this group (22%, in contrast to 70% in the IG). Capillary density and degree of fibrosis were determined in weeks 3 and 4, and also showed a clear benefit as a result of the use of the G-CSF and VEGF genes together.Conclusions Gene therapy using VEGF and G-CSF demonstrated a synergistic effect promoting vessel and tissue repair in mouse hind limb ischemia. Copyright (C) 2010 John Wiley & Sons, Ltd.
ISSN: 1099-498X
Other Identifiers:
Appears in Collections:Artigo

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.